Biotech Acquisition Co (Biotech Acquisition Co) EV-to-Revenue : (As of May. 24, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Biotech Acquisition Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Biotech Acquisition Co's enterprise value is $292.10 Mil. Biotech Acquisition Co's Revenue for the trailing twelve months (TTM) ended in Sep. 2022 was $0.00 Mil. Therefore, Biotech Acquisition Co's EV-to-Revenue for today is .

The historical rank and industry rank for Biotech Acquisition Co's EV-to-Revenue or its related term are showing as below:

BIOT's EV-to-Revenue is not ranked ^*
in the Diversified Financial Services industry.
Industry Median: 4.09
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-24), Biotech Acquisition Co's stock price is $10.15. Biotech Acquisition Co's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2022 was $0.00. Therefore, Biotech Acquisition Co's PS Ratio for today is .

Biotech Acquisition Co EV-to-Revenue Historical Data

The historical data trend for Biotech Acquisition Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotech Acquisition Co EV-to-Revenue Chart

Biotech Acquisition Co Annual Data

Trend

Dec20

Dec21

EV-to-Revenue

Biotech Acquisition Co Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
EV-to-Revenue	Get a 7-Day Free Trial				-	-	-	-	-

Competitive Comparison of Biotech Acquisition Co's EV-to-Revenue

For the Shell Companies subindustry, Biotech Acquisition Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biotech Acquisition Co's EV-to-Revenue Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Biotech Acquisition Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Biotech Acquisition Co's EV-to-Revenue falls into.

Biotech Acquisition Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Biotech Acquisition Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	292.104	/	0
	=

Biotech Acquisition Co's current Enterprise Value is $292.10 Mil.
Biotech Acquisition Co's Revenue for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Biotech Acquisition Co (NAS:BIOT) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Biotech Acquisition Co's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	10.15	/	0
	=

Biotech Acquisition Co's share price for today is $10.15.
Biotech Acquisition Co's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

Biotech Acquisition Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Biotech Acquisition Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotech Acquisition Co (Biotech Acquisition Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Biotech Acquisition Co (NAS:BIOT) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

545 West 25th Street, 20th Floor, New York, NY, USA, 10001

Website

Biotech Acquisition Co is a blank check company.

Executives

Albert F Hummel	director, officer: Chief Investment Officer	PO BOX 3407, RANCHO SANTA FE CA 92067
Biotech Sponsor Llc	10 percent owner	545 W. 25TH ST., 20TH FLOOR, NEW YORK NY 10001
Bruno Montanari	director	545 WEST 25TH STREET, 20TH FLOOR, NEW YORK NY 10001
Ivan Jarry	officer: Chief Operating Officer	545 WEST 25TH STREET, 20TH FLOOR, NEW YORK NY 10001
Paul Bernard	director	545 WEST 25TH STREET 20TH FL, NEW YORK NY 10001
Aaron Kim	director	545 WEST 25TH STREET 20TH FL, NEW YORK NY 10001
Michael Schleifer	director, 10 percent owner, officer: Chief Executive Officer	545 WEST 25TH STREET 20TH FLOOR, NEW YORK NY 10001
Thomas Fratacci	officer: CFO & Treasurer	545 WEST 25TH STREET, 20TH FLOOR, NEW YORK NY 10001